
Eko Health: An American tech firm innovating in medical devices and AI for cardiovascular care.
Eko Health, founded in 2013, is an American healthcare technology company dedicated to revolutionizing cardiovascular and pulmonary care through advanced medical devices, software, and clinical support AI. The company's core mission is to enhance the detection and management of heart and lung diseases by integrating cutting-edge digital technology with traditional medical tools. Eko Health offers products like the Eko CORE™ Digital Stethoscope, which combines TrueSound™ audio with ECG capabilities, and the Eko CORE™ Digital Attachment that transforms analog stethoscopes into digital devices. Their market focus includes healthcare professionals and institutions aiming to improve diagnostic accuracy and patient outcomes.
Notable affiliations include partnerships with leading medical device manufacturer 3M™ Littmann®, which has integrated Eko's CORE™ digital technology into its cardiology-grade stethoscopes. Eko Health has attracted significant investment from venture capital firms and healthcare-focused investors, enabling rapid growth and innovation. Key achievements include FDA clearance for their AI algorithms designed to detect heart murmurs and atrial fibrillation. Overall, Eko Health has made a substantial impact on the medical field by providing clinicians with enhanced tools for early disease detection and improved patient care.
Companies similar to Eko Health include AliveCor, Steth IO, Stat Health and Cardiac Insight.
Eko Health was founded in 2013.
Eko Health's headquarters is located in Emeryville, CA, US.
Eko Health's most recent funding round was for $2.7M (USD) in September 2022.
As of Sep 20, 2022, Eko Health has raised a total of $128.2M (USD).
Eko Health has 153 employees as of Feb 4, 2024.
Stat Health
stat-health.com